,drug,MOAs
27,COc1cc(C[C@H]2C(=O)OC[C@@H]2Cc2ccc(OC)c(OC)c2)ccc1O,MEK inhibitor
173,Cc1cc(O)c2c(=O)c3c(O)cc(O)c4c5c(O)cc(O)c6c(=O)c7c(O)cc(C)c8c1c2c(c34)c(c78)c65,tyrosine kinase inhibitor
184,Cc1cn[nH]c1,alcohol dehydrogenase inhibitor
176,Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1,FGFR inhibitor|VEGFR inhibitor
198,CC(C)C[C@@H](C=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1,proteasome inhibitor
79,C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1,WEE1 kinase inhibitor
48,Nc1nc2cc(Cl)ccc2o1,myorelaxant
228,O=C(O)COc1cccc(-c2ocnc2-c2nc(-c3ccccc3)c(-c3ccccc3)o2)c1,IP1 prostacyclin receptor agonist
177,COc1cccc2c1C(=O)c1c(O)c3c(c(O)c1C2=O)C[C@@](O)(C(C)=O)C[C@H]3O[C@H]1C[C@H](N)[C@H](O)[C@H](C)O1,RNA synthesis inhibitor|topoisomerase inhibitor
113,CCCCCCCCCCC(C)(C)C(=O)Nc1c(OC)cc(OC)cc1OC,ACAT inhibitor
150,CCc1nc(N)nc(N)c1-c1ccc(Cl)cc1,dihydrofolate reductase inhibitor
210,Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1,Abl kinase inhibitor|Bcr-Abl kinase inhibitor
201,CCCn1cnc2c1c(=O)n(CCCCC(C)=O)c(=O)n2C,adenosine reuptake inhibitor|phosphodiesterase inhibitor
211,COc1cc2nc(N3CCCN(C)CC3)nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC,histone lysine methyltransferase inhibitor
225,C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl,ALK tyrosine kinase receptor inhibitor
71,CO[C@]12[C@@H](COC(N)=O)C3=C(C(=O)C(C)=C(N)C3=O)N1CC1N[C@H]12,DNA alkylating agent|DNA synthesis inhibitor
138,CN(C)c1ccc2nc3ccc(N(C)C)cc3[s+]c2c1,guanylyl cyclase inhibitor|nitric oxide production inhibitor
59,Nc1nc(Nc2ccccc2)nc2c1ncn2C1OC(CO)C(O)C1O,adenosine receptor agonist
88,O=C(Nc1cccnc1)N1CCC(Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1,FAAH inhibitor
116,Cc1ccc(S(=O)(=O)OCC(=O)Nc2ccc(C(=O)O)c(O)c2)cc1,STAT inhibitor
99,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1,KIT inhibitor|VEGFR inhibitor
129,COc1c(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)cc2c(c1OC)-c1ccc(SC)c(=O)cc1[C@@H](NC(C)=O)CC2,GABA receptor antagonist
60,CCCCCCCCCCCC1C(=O)C(=O)CC(=O)C1=O,HCV inhibitor|XIAP inhibitor
57,COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC,SYK inhibitor
168,CN1N=C(N)c2cn(C3OC(CO)C(O)C3O)c3ncnc1c23,AKT inhibitor
154,O=C1NC(=O)c2c1c(-c1ccccc1)cc1[nH]c3ccc(O)cc3c21,PKC inhibitor
69,CC#CC1(O)CCC2C3CCC4=CC(=O)CCC4=C3C(c3ccc(N(C)C)cc3)CC21C,glucocorticoid receptor antagonist|progesterone receptor antagonist
25,CN1CCN(C2=Nc3cc(Cl)ccc3Nc3ccccc32)CC1,dopamine receptor antagonist|serotonin receptor antagonist
190,C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)[C@H]4[C@H](O)C[C@]5(C)[C@@H](C6=CC(=O)OC6)CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)[C@H](O)[C@H](O)[C@H]1O,ATPase inhibitor
187,CCN(CC)C(=S)SSC(=S)N(CC)CC,aldehyde dehydrogenase inhibitor|DNA methyltransferase inhibitor|TRPV agonist
20,O=c1c(O)c(-c2ccc(O)c(O)c2)oc2cc(O)cc(O)c12,polar auxin transport inhibitor
180,N[C@@H](Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O,thyroid hormone stimulant
36,O=c1cc(N2CCOCC2)oc2c(-c3cccc4c3sc3ccccc34)cccc12,DNA dependent protein kinase inhibitor
56,C[C@@H]1CC[C@H]2[C@@H](C)C(OC(=O)CCC(=O)O)OC3O[C@]4(C)CC[C@@H]1[C@]32OO4,DNA synthesis inhibitor
50,Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O,KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|VEGFR inhibitor
174,Cc1oncc1C(=O)Nc1ccc(C(F)(F)F)cc1,dihydroorotate dehydrogenase inhibitor|PDGFR tyrosine kinase receptor inhibitor
164,CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O,penicillin binding protein inhibitor
105,CC(C)(C)c1ccc(C=CC(=O)Nc2ccc3c(c2)OCCO3)cc1,TRPV antagonist
203,Nc1c2c(nc3ccccc13)CCCC2,acetylcholinesterase inhibitor
64,CN(C)CCC=C1c2ccccc2CCc2ccccc21,norepinephrine inhibitor|norepinephrine reuptake inhibitor|serotonin receptor antagonist|serotonin√±norepinephrine reuptake inhibitor (SNRI)
144,O[C@@H](COc1cccc2ncccc12)CN1CCN([C@@H]2c3ccccc3[C@@H]3[C@H](c4ccccc42)C3(F)F)CC1,P glycoprotein inhibitor
156,O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1,p38 MAPK inhibitor
21,N=C(NCCc1ccc(I)cc1)SCCCc1c[nH]cn1,histamine receptor antagonist
163,CCCCC(C=O)NC(=O)C(CC(C)C)NC(=O)OCc1ccccc1,calpain inhibitor
6,O=C(C=Cc1cccnc1)NCCCCC1CCN(C(=O)c2ccccc2)CC1,niacinamide phosphoribosyltransferase inhibitor
204,CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1,leukotriene receptor antagonist|lipoxygenase inhibitor
92,O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2C1=NO,glycogen synthase kinase inhibitor|lipoxygenase inhibitor
197,CCN(CC)CCNC(=O)c1c(C)[nH]c(C=C2C(=O)Nc3ccc(F)cc32)c1C,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor
206,CC(C)c1ccc2c(c1)CC[C@@H]1[C@]2(C)CCC[C@@]1(C)CN,cannabinoid receptor agonist
2,C[C@H]1CN([C@H](C)CO)C(=O)c2ccccc2-c2ccccc2CO[C@H]1CN(C)Cc1ccc2c(c1)OCO2,None
3,Cc1cccc(C)c1OCC(=O)N[C@@H](Cc1ccccc1)[C@@H](O)C[C@H](Cc1ccccc1)NC(=O)[C@H](C(C)C)N1CCCNC1=O,HIV protease inhibitor
62,Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21,mTOR inhibitor|PI3K inhibitor
191,CCC1C=CC=CC[C@H](C)[C@@H](O)[C@](C)(O)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@H](C)C=CC(=O)OC2[C@@H](C)C(CC1)OC1(CC[C@@H](C)C(C[C@H](C)O)O1)[C@@H]2C,ATP synthase inhibitor|ATPase inhibitor
11,CC(C)c1ccccc1Cc1cc(C(=O)Nc2ccc(S(=O)(=O)c3ccccc3C(C)(C)C)cc2)c(O)c(O)c1O,BCL inhibitor
61,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC,VEGFR inhibitor
47,CC(C)OC(=O)CCCC=CC[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1CC[C@@H](O)CCc1ccccc1,prostanoid receptor agonist
7,O=C(C=Cc1cccc(S(=O)(=O)Nc2ccccc2)c1)NO,HDAC inhibitor
192,O=C(C=Cc1ccc(O)cc1)c1ccc(O)cc1O,guanylate cyclase activator
70,COC[C@@H](c1ccc(C(F)(F)F)cc1)N1CCN(C2(C)CCN(C(=O)c3c(C)ncnc3C)CC2)C[C@@H]1C,CC chemokine receptor antagonist
122,NS(=O)(=O)OC[C@@H]1C[C@@H](n2ccc3c(N[C@H]4CCc5ccccc54)ncnc32)C[C@@H]1O,nedd activating enzyme inhibitor
53,CC12CCC3c4ccc(O)cc4CC(CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)C3C1CCC2O,estrogen receptor antagonist
170,Nc1ncn([C@H]2C[C@H](O)[C@@H](CO)O2)c(=O)n1,DNA methyltransferase inhibitor
151,C=C(C)[C@@H]1CC[C@]2(C(=O)O)CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12,apoptosis stimulant|NFkB pathway inhibitor
118,CNCCC[C@]12CC[C@H](c3ccccc31)c1ccccc12,norepinephrine reputake inhibitor|tricyclic antidepressant
100,O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1,ATM kinase inhibitor
8,CSc1ccc2c(c1)N(CCC1CCCCN1C)c1ccccc1S2,dopamine receptor antagonist
234,CC1=CC(=O)c2ccccc2C1=O,mitochondrial DNA polymerase inhibitor|phosphatase inhibitor
40,CCCCC1=NC2(CCCC2)C(=O)N1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1,angiotensin receptor antagonist
77,CC(C=CC=C(C)/C=C/C1=C(C)CCCC1(C)C)=CC(=O)Nc1ccc(O)cc1,apoptosis stimulant|retinoid receptor agonist
162,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1,FLT3 inhibitor|KIT inhibitor|PDGFR tyrosine kinase receptor inhibitor|RAF inhibitor|RET tyrosine kinase inhibitor|VEGFR inhibitor
133,CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O,focal adhesion kinase inhibitor
131,Cc1ccccc1C(OCCN(C)C)c1ccccc1,acetylcholine receptor antagonist
200,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1,FLT3 inhibitor|JAK inhibitor
196,CCCCCC(=O)O[C@]1(C(C)=O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@@]21C,progesterone receptor agonist
123,Clc1ccc(COC(Cn2ccnc2)c2ccc(Cl)cc2Cl)cc1,lanosterol demethylase inhibitor|sterol demethylase inhibitor
111,Cc1cccc(N(C)C(=S)Oc2ccc3ccccc3c2)c1,fungal squalene epoxidase inhibitor
167,Cc1ccc(C=C2CNCC(=Cc3ccc(C)cc3)C2=O)cc1,ubiquitin specific protease inhibitor
73,Cc1cc(C(C)Nc2ccccc2)c2nc(N3CCOCC3)cc(=O)n2c1,PI3K inhibitor
222,Cc1cc(I)ccc1Nc1c(C(=O)NOCC2CC2)cc(F)c(F)c1F,MAP kinase inhibitor|MEK inhibitor
161,Nc1nc(S)c2ncn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c2n1,purine antagonist
84,Fc1ccc(C(OCCN2CCN(CCCc3ccccc3)CC2)c2ccc(F)cc2)cc1,dopamine uptake inhibitor
226,C#C[C@]1(O)CCC2C3CCc4cc(O)ccc4C3CC[C@@]21C,estrogen receptor agonist|estrogenic hormone
104,O=C(Nc1c[nH]nc1-c1nc2cc(CN3CCOCC3)ccc2[nH]1)NC1CC1,Aurora kinase inhibitor|JAK inhibitor
44,Nc1nc(N)c2nc(-c3ccccc3)c(N)nc2n1,sodium channel blocker
218,Oc1c(I)cc(Cl)c2cccnc12,chelating agent
22,Nc1nc2ccc(Cl)cc2c2nc(-c3ccco3)nn12,adenosine receptor antagonist
149,CC(=O)S[C@@H]1CC2=CC(=O)CC[C@]2(C)[C@H]2CC[C@@]3(C)[C@@H](CC[C@@]34CCC(=O)O4)[C@@H]21,mineralocorticoid receptor antagonist
38,O=C1NC(=O)C(c2ccccc2[N+](=O)[O-])=C1Nc1ccc(O)c(Cl)c1,glycogen synthase kinase inhibitor
195,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(C=Cc3ccccc3)n2)n[nH]1,Aurora kinase inhibitor|FLT3 inhibitor|VEGFR inhibitor
76,COC(=O)[C@H]1[C@H]2C[C@@H]3c4[nH]c5cc(OC)ccc5c4CCN3C[C@H]2C[C@@H](OC(=O)c2cc(OC)c(OC)c(OC)c2)[C@@H]1OC,vesicular monoamine transporter inhibitor
121,Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1,Aurora kinase inhibitor|Bcr-Abl kinase inhibitor|FLT3 inhibitor|JAK inhibitor
183,COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C,HIV integrase inhibitor
96,Nc1nc(Cl)nc2c1ncn2C1OC(CO)C(O)C1F,ribonucleotide reductase inhibitor
132,CCOc1ccccc1-n1c(C(C)N2CCN(C(=O)COc3ccc(Cl)cc3)CC2)nc2ccccc2c1=O,ion channel antagonist
186,CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12,calcium/calmodulin dependent protein kinase inhibitor|purinergic receptor antagonist
146,COc1ccc2c(c1)[C@]13CCCC[C@@H]1[C@H](C2)N(C)CC3,glutamate receptor antagonist|sigma receptor agonist
68,CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4,FLT3 inhibitor|KIT inhibitor|PKC inhibitor
67,CCC(=C(c1ccccc1)c1ccc(OCCN(C)C)cc1)c1ccccc1,estrogen receptor antagonist|selective estrogen receptor modulator (SERM)
165,C[C@]12CC[C@@H]3c4ccc(O)cc4CC[C@H]3[C@@H]1CC[C@@H]2O,estrogen receptor agonist
23,CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O,histamine receptor agonist
